Warning: The NCBI web site requires JavaScript to function. more...
Analysis of airway secretions in a model of sulfur dioxide induced chronic obstructive pulmonary disease (COPD).
Wagner U, Staats P, Fehmann HC, Fischer A, Welte T, Groneberg DA.
J Occup Med Toxicol. 2006 Jun 7;1:12.
Related citations
Chronic exposure to sulfur dioxide. Physiologic and histologic evaluation of dogs exposed to 50 or 15 ppm.
Scanlon PD, Seltzer J, Ingram RH Jr, Reid L, Drazen JM.
Am Rev Respir Dis. 1987 Apr;135(4):831-9.
The spontaneously hypertensive rat: an experimental model of sulfur dioxide-induced airways disease.
Kodavanti UP, Schladweiler MC, Ledbetter AD, Ortuno RV, Suffia M, Evansky P, Richards JH, Jaskot RH, Thomas R, Karoly E, Huang YC, Costa DL, Gilmour PS, Pinkerton KE.
Toxicol Sci. 2006 Nov;94(1):193-205. Epub 2006 Aug 23.
Diffuse alveolar damage in the rat lung after short and long term exposure to nitrogen dioxide.
Barth PJ, Uhlarik S, Bittinger A, Wagner U, Rüschoff J.
Pathol Res Pract. 1994 Jan;190(1):33-41.
Models of chronic obstructive pulmonary disease.
Groneberg DA, Chung KF.
Respir Res. 2004 Nov 2;5:18. Review.
Sulfur dioxide induced bronchitis in rats.
White R, Zoppi AL, Haroz RK, Broillet A.
Arch Toxicol Suppl. 1986;9:431-5.
Establishment and pathological study of models of chronic obstructive pulmonary disease by SO2 inhalation method.
Xu J, Zhao M, Liao S.
Chin Med J (Engl). 2000 Mar;113(3):213-6.
Effects of 0.5 ppm ozone on glycoprotein secretion, ion and water fluxes in sheep trachea.
Phipps RJ, Denas SM, Sielczak MW, Wanner A.
J Appl Physiol. 1986 Mar;60(3):918-27.
Mucus hypersecretion in chronic obstructive pulmonary disease.
Rogers DF.
Novartis Found Symp. 2001;234:65-77; discussion 77-83. Review.
The role of airway secretions in COPD: pathophysiology, epidemiology and pharmacotherapeutic options.
COPD. 2005 Sep;2(3):341-53. Review.
Physiology of airway mucus secretion and pathophysiology of hypersecretion.
Respir Care. 2007 Sep;52(9):1134-46; discussion 1146-9. Review.
NTP Toxicity Study Report on the atmospheric characterization, particle size, chemical composition, and workplace exposure assessment of cellulose insulation (CELLULOSEINS).
Morgan DL.
Toxic Rep Ser. 2006 Aug;(74):1-62, A1-C2.
Development and characterization of a rat model of chronic obstructive pulmonary disease (COPD) induced by sidestream cigarette smoke.
Zheng H, Liu Y, Huang T, Fang Z, Li G, He S.
Toxicol Lett. 2009 Sep 28;189(3):225-34. Epub 2009 Jun 12.
Experimental COPD induced by solid combustible burn smoke in rats: a study of the emphysematous changes of the pulmonary parenchyma.
Murărescu ED, Eloae-Zugun F, Mihailovici MS.
Rom J Morphol Embryol. 2008;49(4):495-505.
NTP technical report on the toxicology and carcinogenesis studies of 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) (CAS No. 1746-01-6) in female Harlan Sprague-Dawley rats (Gavage Studies).
National Toxicology Program.
Natl Toxicol Program Tech Rep Ser. 2006 Apr;(521):4-232.
Cell morphological ultrastructural changes in various organs from mice exposed by inhalation to sulfur dioxide.
Meng Z, Liu Y.
Inhal Toxicol. 2007 May;19(6-7):543-51.
Effect of exposure to 500 ppm sulfur dioxide on the lungs of the ferret.
Miller ML, Andringa A, Rafales L, Vinegar A.
Respiration. 1985;48(4):346-54.
Rosiglitazone, a peroxisome proliferator-activated receptor-gamma agonist, attenuates acrolein-induced airway mucus hypersecretion in rats.
Liu DS, Liu WJ, Chen L, Ou XM, Wang T, Feng YL, Zhang SF, Xu D, Chen YJ, Wen FQ.
Toxicology. 2009 Jun 16;260(1-3):112-9. Epub 2009 Apr 5.
The non-human primate as a model for studying COPD and asthma.
Plopper CG, Hyde DM.
Pulm Pharmacol Ther. 2008 Oct;21(5):755-66. Epub 2008 Feb 1. Review.
Sulfur dioxide induced airway hyperreactivity in allergic sheep.
Abraham WM, Oliver W Jr, Welker MJ, King M, Chapman GA, Yerger L, Maurer DR, Sielczak M, Wanner A, Sackner MA.
Am J Ind Med. 1980;1(3-4):383-90.
Filter your results:
Your browsing activity is empty.
Activity recording is turned off.
Turn recording back on